Ensuring Vaccine Cold-Chain Integrity

Glycerol as a Stabilizer of Endoxylase

Marketed mAb Formulations

Freeze-Thaw-Induced Aggregation of mAbs

Stabilization of rAAV2 during Purification

Glycerol Reduces Chemical Degradation

Photodegradation of a Fab Fragment

Review of HC mAb Formulations

Buffer and pH Effects on an IgG4 mAb

Temperature Effects on Aggregation

Effects of Controlled Ice Nucleation

Stability of Lyophilized Polypeptides

Mannitol Crystallization in Spray-Dried GH

Stabilizers for Proteins in Solution

mAb Stability at the Air-Water Interface

Downstream Processing Stresses on AAVs

Designing Protein-Stabilizing DES

Colloidal Stability of mAbs

Optimization of Formulation Development

Solution Behavior of Poloxamer 188

Hydrophobicity assay for Developability

RP-HPLC Assay for Co-Formulated mAbs

Hydrogel for Sustained Release of mAbs

Effect of Tungsten Impurities from PFS

Ubiquitin Stabilization by Proline

Formulation and Oral Delivery of GLP-1

Antibody-Oligonucleotide Conjugates

Ultrahigh Concentration mAb Formulations

Visual Inspection of Parenterals

Shear-Induced Aggregation of Insulin

Small Peptides as Excipients for Proteins

F/T Stress and Protein Aggregation

Measuring Apparent Protein Solubility

Optimizing Multispecific Antibodies

Use of Met in HC mAb Formulations

Risk of SVP Formation in mAb Formulation

Cryoconcentration of Biologic BDS

Developability Assessment of mAbs

Atypical Dynamics of HMW Species

Annealing and Lyophilization

Choline Chloride as a Protective Osmolyte

Bubble Formation in Lyo Formulations

Dynamic Clusters in mAb Formulations

Effect of Preservatives on mAb Stability

Sugars and Stability of Lyophilized Proteins

Stability of Nonglycosylated mAbs

Prediction of Viscosity Behavior of mAbs

Placebos for s.c. mAb Drug Products

Perspective on High-Dose Biologics

P188 and PEG/PPG-Based Formulations

Electrostatics and Viscosity of Antibodies

Chemical Stability of Liraglutide

Buffer-Free Protein Formulations

Preformulation Study on Semaglutide

Formulation Development for Biosimilars

Solid RNA-Lipid Nanoparticle Formulations

ATP Stabilization of HSA

Photostability of ADCs

mAb Stability in Sustained Release Products

mAb Mutation Effects on Colloidal Stability

Viscosity Reduction using Ionic Liquids

Review of Viscosity-Reducing Excipients

Predicting pH Shifts during Dialysis

Degradation Profiles of Biosimilars

Development of RNA-Based Therapeutics

ISRs with Subcutaneous IgG Infusion

Spin-Freeze-Drying of a PEGylated Peptide

Delivery Systems for DNA and RNA

Higher Order Structure of Oligonucleotides

Overview of Deamidation

Buffer Effects on Cyclodextrin Complexes

Effects of Mutations on Protein Stability

High Dose/High Concentration Products

Particle Analysis by BMI

mAbs and Surfactants at Air-Water Interface

Preservatives and Tubing

mAb Formulation Development: Editorial

Solubility Assessment using PEG Pptn

Alternatives to Polysorbates

Aggregation of a Amylin Agonist Conjugate

Specific Binding of Mg Ions to a Protease

Development of Placebos for Biologics

Impact of pH Change upon Use of Dry Ice

mAb Aggregation by Mass Spectrometry

Stabilization of Aerosolized mRNA-LNPs

pH-Shift-Induced Aggregation of IgGs

Precipitation and mAb Solid Dosage Forms

Trehalose/HP-b-CD for Spray Dried mAbs

Rescue of AAV Filter Losses by Surfactants

Solid mAb Dosage Forms by Precipitation

Surfactants and Dripping of mAb Solutions

mAb Gelation under Low pH Conditions

Relaxation in Lyophilized Formulations

Alternative Surfactants for Biologics

Interfacial Stress and Aggregation of BSA

Overview of Aggregation of Protein Drugs

Survey of Aggregation Analytical Methods

Effect of Initial Aggregate Level for mAbs

Modulation of mAb Colloidal Stability

Water Mobility in Lyophilized HSA

Use of Arg during Ultrafiltration

Particle Formation during Pumping

mAb Aggregation during Administration

Manufacturing Challenges for Lyophiles

mAb Adsorption at the Air-Water Interface

ILs as Potential New Vaccine Adjuvants

Osmolyte-Induced Stabilization Mechanism

Protein Stability in Frozen Solutions

Lyoprotection of Taq DNA Polymerase

Dry Powder Bacteriophage Formulation

Protein-Peptide Coformulation

Parenteral Peptide Product Development

Polysorbate Analysis with HPLC-CAD

Effect of Surfactants on Protein Structure

Cyclodextrins and Lysozyme Stability

mRNA Stabilization and Formulation

Formulation of Oncolytic Viruses

Chelating Agents and mAb Oxidation

Subvisible Particle Formation

Freezing-Induced Denaturation of MP

Vibrational Damage to Lyophilized Protein

Subcutaneous Delivery of HC mAbs

Inhibition of Urea-Induced Aggregation

Evaluation of Novel Surfactants

Clouding Behavior of Polysorbate 80

High-Throughput Screening for Oxidation

Silicone Oil and Dupliximab Stability

Perspective on Predictive Stability

Analytical Control Strategy for Biologics (2)

LLPS of HC mAb Formulations

Arg, Hydration and Protein Stability (2)

Glucagon Oxidation and Aggregation

PS 20/80 and Peptide-Protein Formulations

Subvisible Particle Risks in mAbs

Vaccine Formulation Design

Preformulation Study on hMANF

Arg Effects on Cytochrome c

Betaine as a Stabilizer for Aβ (25-35)

Pore Structure Variance in Lyo Cakes

Thermal Interactions between Lyo Vials

Modulation of Insulin Aggregation

Developability Framework for mAbs

in vitro Serum Stability Assay for mAbs

Filling HC Biopharmaceutical Formulations

Interactions of Sugars with Lysozyme

Polyphosphate and Aggregation Suppression

Photostability of үD-Crystallin

Vial Quality and Frozen Drug Products

SVP Profile for Ophthalmic Proteins

Prediction of Viscosity of mAb Solutions

Excipients in Ophthalmic Products

Liposomes and s.c. Delivery of mAbs

Single-Step Lyophilization of Proteins

Freezing-Induced Damage of a Bispecific

Prediction of mAb Viscosity Behavior

Protein Adsorption during Manufacturing

Protein Stabilization and Spray Drying (2)

Excipients and Phenol-Induced Precipitation

Studying mAb Aggregation

Intervention in Insulin Fibrillation

Stability of Advanced Biologic Therapeutics

Formulation Development of ADCs

Ionic Liquids as Protein Stabilizers

Agitation-Induced Aggregation Propensity

Vial Fogging in Lyophilized Products

Predicting Long-Term Stability of mAbs

Water and Deamidation of Dried Proteins

Combination of Cyclodextrin/Carrageenan

Cyclodextrin and Lysozyme Denaturation

Particle Formation during Pumping

Self-Association of mAbs by QCM-D

Monitoring AAV Stability Using HIC

Sterile Filtration and Particle Formation

Ultra-High Concentration Formulations

Ectoines as Possible Stabilizers of GH

Bubbles during Reconstitution of Etanercept

Polysaccharide Effects on Dried Proteins

Polysorbate-Degrading Enzymes

Lipidation Effects on GLP-1

Mannitol Crystallization in the Frozen State

Enhanced Stabilization of Dried Probiotics

DLS as a QC Tool for Labeled Antibodies

Search for Viscosity-Reducing Excipients

Formulation of a CMV Vaccine

Fattigation Technologies for Medicinals

Syringe Handling during IgG Dilution

Oxidative Stress Testing of Trastuzumab

Osmolyte Screening as Stabilizers

Silanol Density and mAb Stability

Stability of IV Preparations of an ADC

LLPS and Stability of IgY

Excipient-mAb Interactions

Stabilization of Biologics in the Solid State

In Vivo Deamidation of mAbs

Glycine as a Stabilizer of a Luciferase

Protein Stabilization by Zwitterions

Formulation Effects on Trastuzumab

Stabilization by Trehalose Nanoparticles

Fragmentation of an IgG1 mAb

Lyophilized Formulations of AAV5

Lyophilized Formulations of mRNA-LNPs

Trehalose Stabilization of IgG1s

Stabilization of Senecavirus Antigen

Protein-Polyelectrolyte Complexes of IgGs

L-Tyrosine as a Stabilizer

Competitive Adsorption of PS 80 and mAb

Impact of Citrate on PS 80 Degradation

His Accelerates Fe-Catalyzed Oxidation

HSA Slows Amyloid Formation

Effect of Excipients on Colloidal Stability

Trisulfide Bond Formation in Proteins

Aggregation of Antibodies

Amphiphilic Excipients to Stabilize Proteins

Insulin Degradation in the Solid-State

Development of Lyo Protein Products

PAT Methods for Co-Formulated mAbs

Aggregation in Frozen State Upon Dropping

HTS and HC Protein Formulations

HTS and HC Trastuzumab Formulation

Buffers and HC Lyo Formulations

Amyloid Aggregation Databases

CEX and mAb Co-Formulations

MD and Protein-Excipient Interactions

Quantitation of Surfactants using qNMR

Stabilizers for Erythopoietin (EPO)

Stabilization of Infliximab by HP-β-CD

Destabilization by Polyamines

Removal of Surfactants from mAb Solutions

2-MIDHP as a Stabilizer of mAbs

Role of Arg with Peptides and Proteins

Effect of UVC Irradiation on Lysozyme

Fe (III)/Citrate Effects on Photostability

Photodegradation of Fe(III)-Lactate

Fluorochemical Carriers for Biologics

Injectability of HC Suspensions

Hexametaphosphate as a Stabilizer

Advances in Polypeptide PEGylation

Modification Strategies for Peptides/Proteins

Effect of Cyclodextrins on ADC Stability

Sucrose vs. Trehalose as Stabilizers

Protein-Buffer Interactions by NMR

Factors Influencing Polysorbate Stability

Oleic Acid and mAb Particle Formation

Stabilization by HP-β-CD with Electrolytes

Fibrillation Inhibition by ATP

Buffer Effects on Ultrafiltration of BSA

Overview of Protein Glycation

Review of Oxidation of Food Proteins

Developability Consideration for Bispecifics

Predicting Viscosity of HC mAb Solutions

Machine Learning and LNP Development

Solid-State Behavior of Lyophilized IgG2

Impact of Sugar-to-mAb Ratio on Stability

Buffer Effects on Lyo Protonation State

Protein-Polysorbate Interactions

Insulin Aggregation

Thermal and pH Stress Effects on mAbs

Supercooling and Vaccine Stability

Condensates and Protein Aggregation

Arg Suppresses TTR Aggregation